Franklin Genomic Advancements ETF Rating $26.52 -3.55 (-11.81%) Closing price 04/1/2025 03:49 PM EasternExtended Trading$26.51 -0.01 (-0.05%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy 2.76Holdings in HELX have an aggregate rating of Moderate Buy based on 875 analyst ratings issued in the past year covering 63 companies (90.2% of the portfolio).HELX Aggregate Price Target$26.52High Prediction$26.52Average Prediction$26.52Low Prediction$26.52Holdings in HELX have an aggregate price target of $26.52 and a range of $26.52 to $26.52 covering 63 companies (90.2% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy14 Buy rating(s)Moderate Buy37 Moderate Buy rating(s)Hold11 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 63 HELX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.48%NTRANatera$140.65-0.5%3.832 of 5 stars3.00$178.12 26.6%16Insider TradeShort Interest ↑News CoveragePositive NewsGap Down5.17%KRYSKrystal Biotech$174.58-3.2%4.8376 of 5 stars3.00$220.00 26.0%8Positive News5.08%VRTXVertex Pharmaceuticals$484.740.0%3.9219 of 5 stars2.65$509.17 5.0%26Analyst ForecastPositive News3.80%REGNRegeneron Pharmaceuticals$617.00-2.7%4.8126 of 5 stars2.76$966.88 56.7%25Analyst ForecastShort Interest ↑Positive News3.57%MEDPMedpace$297.73-2.3%4.72 of 5 stars2.38$376.30 26.4%13Short Interest ↓Positive NewsHigh Trading Volume3.38%TMOThermo Fisher Scientific$482.51-3.0%4.9137 of 5 stars2.82$653.23 35.4%22Positive News3.35%LLYEli Lilly and Company$803.70-2.7%4.9441 of 5 stars2.85$1,009.72 25.6%203.02%AZNAstraZeneca$72.60-1.2%2.9941 of 5 stars3.10$89.75 23.6%10Positive News2.70%CTVACorteva$63.54+1.0%4.3717 of 5 stars2.72$68.06 7.1%18Analyst UpgradePositive News2.61%BNTXBioNTech$90.29-0.8%2.8266 of 5 stars2.89$143.44 58.9%18Analyst Forecast2.55%UTHRUnited Therapeutics$306.88-0.5%4.9328 of 5 stars2.67$388.25 26.5%12Short Interest ↓News CoveragePositive News2.49%INSMInsmed$72.00-5.6%4.383 of 5 stars3.00$94.00 30.6%16Positive News2.25%DHRDanaher$200.09-2.4%4.9569 of 5 stars2.81$278.24 39.1%21Positive News2.14%TWSTTwist Bioscience$38.94-0.8%4.0432 of 5 stars2.70$54.40 39.7%10Positive News2.06%RVTYRevvity$104.24-1.5%3.5077 of 5 stars2.77$136.25 30.7%13Positive News2.00%RAREUltragenyx Pharmaceutical$33.84-6.5%4.4099 of 5 stars2.93$92.79 174.2%141.99%GHGuardant Health$42.47-0.3%4.2722 of 5 stars3.00$48.95 15.3%20Positive News1.97%ALNYAlnylam Pharmaceuticals$255.76-5.3%4.4078 of 5 stars2.77$316.25 23.7%26Analyst ForecastPositive News1.85%CDNSCadence Design Systems$258.79+1.8%4.7398 of 5 stars2.75$324.83 25.5%12Short Interest ↑Positive News1.77%EXASExact Sciences$43.45+0.4%4.4747 of 5 stars2.90$70.26 61.7%21Positive News1.71%SRPTSarepta Therapeutics$61.91-3.0%4.8283 of 5 stars2.78$164.05 165.0%23Analyst DowngradeHigh Trading Volume1.52%CRLCharles River Laboratories International$145.82-3.1%4.7612 of 5 stars1.94$189.77 30.1%161.47%LGNDLigand Pharmaceuticals$104.82-0.3%4.4785 of 5 stars3.00$147.00 40.2%6Short Interest ↑Positive NewsGap Up1.45%BBIOBridgeBio Pharma$33.02-4.5%4.5991 of 5 stars2.92$52.64 59.4%12Analyst ForecastOptions VolumeGap Down1.44%QGENQiagen$39.51-1.6%3.565 of 5 stars2.30$47.71 20.8%10Short Interest ↑1.36%RGENRepligen$128.50+1.0%4.7469 of 5 stars2.57$178.64 39.0%14Positive News1.34%AAgilent Technologies$113.67-2.8%4.3797 of 5 stars2.46$150.83 32.7%13Positive News1.24%BMRNBioMarin Pharmaceutical$67.94-3.9%4.9272 of 5 stars2.71$94.00 38.4%24Analyst DowngradePositive News1.23%LHLaboratory Co. of America$232.630.0%4.7783 of 5 stars2.86$269.92 16.0%14Insider TradeNews CoveragePositive News1.04%IQVIQVIA$171.11-2.9%4.7995 of 5 stars2.86$249.05 45.6%21Positive News1.02%ADPTAdaptive Biotechnologies$7.52+1.2%3.9798 of 5 stars3.00$9.40 25.0%50.99%NBIXNeurocrine Biosciences$107.00-3.3%4.9202 of 5 stars2.83$165.38 54.6%23Positive News0.98%TEMTempus AI$47.22-2.1%2.5795 of 5 stars2.50$61.18 29.6%12Short Interest ↑0.94%RXRXRecursion Pharmaceuticals$5.09-3.8%2.1305 of 5 stars2.40$8.25 62.1%50.93%TECHBio-Techne$57.35-2.2%4.8715 of 5 stars2.56$81.25 41.7%9Short Interest ↑Positive News0.92%BRKRBruker$40.38-3.3%4.784 of 5 stars2.55$70.50 74.6%11Short Interest ↑Positive News0.91%BEAMBeam Therapeutics$17.64-9.7%3.1879 of 5 stars3.00$49.45 180.4%14Short Interest ↑High Trading Volume0.88%DOCSDoximity$56.67-2.3%3.4428 of 5 stars2.57$64.22 13.3%21Positive News0.82%AZTAAzenta$34.12-1.5%3.5179 of 5 stars2.40$58.75 72.2%5Positive News0.79%IONSIonis Pharmaceuticals$27.26-9.6%4.2426 of 5 stars2.67$58.37 114.1%21Analyst ForecastNews CoverageHigh Trading Volume0.78%VCYTVeracyte$29.56-0.3%4.5349 of 5 stars2.70$43.40 46.8%100.66%BIOBio-Rad Laboratories$239.97-1.5%4.3237 of 5 stars2.60$395.20 64.7%50.60%DVAXDynavax Technologies$12.71-2.0%4.2179 of 5 stars2.33$21.50 69.2%3Positive News0.57%GRALGrail$25.10-1.7%0.7723 of 5 stars2.00$20.00 -20.3%3Positive NewsGap Up0.55%AREAlexandria Real Estate Equities$91.10-1.5%4.5602 of 5 stars2.18$118.60 30.2%11Positive News0.50%ICLRICON Public$166.56-4.8%4.4706 of 5 stars2.80$272.50 63.6%150.49%SDGRSchrödinger$18.84-4.6%2.5845 of 5 stars3.00$32.29 71.4%80.46%WGSGeneDx$84.59-4.5%2.1139 of 5 stars2.50$72.33 -14.5%60.40%BMYBristol-Myers Squibb$59.53-2.4%3.8795 of 5 stars2.33$57.86 -2.8%18Short Interest ↑Analyst RevisionPositive News0.39%AVTRAvantor$15.79-2.6%4.8023 of 5 stars2.77$25.50 61.5%13News CoveragePositive News0.38%VYGRVoyager Therapeutics$3.37-0.3%4.5298 of 5 stars3.11$13.97 314.4%90.29%PTCTPTC Therapeutics$46.60-8.6%3.8709 of 5 stars2.53$63.77 36.8%15Analyst ForecastNews CoverageHigh Trading Volume0.27%CRSPCRISPR Therapeutics$33.14-2.6%3.2429 of 5 stars2.48$73.11 120.6%210.25%CPRXCatalyst Pharmaceuticals$23.92-1.4%4.86 of 5 stars3.13$32.29 35.0%80.25%TVTXTravere Therapeutics$17.44-2.7%2.6775 of 5 stars2.93$31.46 80.4%14Analyst ForecastNews CoveragePositive News0.24%WVEWave Life Sciences$7.74-4.2%4.5507 of 5 stars3.00$22.60 192.0%10Analyst RevisionGap Down0.22%CDNACareDx$17.70-0.3%3.2877 of 5 stars2.57$31.83 79.8%7Positive NewsGap Up0.21%MRNAModerna$27.16-4.2%4.3993 of 5 stars2.04$59.00 117.2%240.14%NGNENeurogene$9.65-17.6%2.3092 of 5 stars3.13$59.80 519.7%8High Trading Volume0.13%RCKTRocket Pharmaceuticals$5.81-12.9%4.5575 of 5 stars2.92$43.00 640.1%12High Trading Volume0.10%NTLAIntellia Therapeutics$6.66-6.3%4.4446 of 5 stars2.63$37.56 463.9%19High Trading Volume0.09%SLPSimulations Plus$24.10-1.7%3.9727 of 5 stars3.00$49.40 105.0%7Upcoming EarningsPositive News0.05%FDMT4D Molecular Therapeutics$2.99-7.4%2.8599 of 5 stars2.56$26.71 793.5%9 This page (BATS:HELX) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
